chronic kidney disease

Reata Bags $350M As It Preps Rare Chronic Kidney Disease Drug For FDA
Xconomy
Thu, 06/11/20 - 10:42 pm
Reata Pharmaceuticals
kidney disease
Alport
chronic kidney disease
bardoxolone methyl
Astellas' Anemia Drug Roxadustat Shows Non-Inferiority to Amgen's Aranesp
BioSpace
Mon, 06/8/20 - 11:36 pm
Astellas
clinical trials
roxadustat
Amgen
Aranesp
anemia
chronic kidney disease
AstraZeneca's Farxiga Shows 'Overwhelming Efficacy' in Phase III CKD Trial
BioSpace
Mon, 03/30/20 - 08:12 pm
AstraZeneca
chronic kidney disease
clinical trials
Farxiga
Easing concerns, FibroGen, AstraZeneca secure FDA date for their anemia drug in broad chronic kidney disease population
Endpoints
Wed, 02/12/20 - 10:50 am
FibroGen
AstraZeneca
FDA
anemia
chronic kidney disease
roxadustat
Ardelyx's kidney disease drug hits goal in phase 3, teeing it up for FDA filing
Fierce Biotech
Tue, 12/3/19 - 10:29 am
Ardelyx
chronic kidney disease
tenapanor
clinical trials
Reata's bardoxolone offers promise in patients with rare kidney disorder
Endpoints
Tue, 11/12/19 - 10:22 am
Reata Pharmaceuticals
Bardoxolone
chronic kidney disease
Alport syndrome
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
CP Wire
Tue, 10/29/19 - 01:55 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Tue, 10/29/19 - 01:54 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
[release] Vascular Therapies Announces Positive Preliminary Clinical Results from its AV Fistula Trials in Patients with Kidney Disease
CP Wire
Tue, 09/10/19 - 09:43 am
Vascular Therapies
clinical trials
Sirogen
chronic kidney disease
[release] Vascular Therapies Announces Positive Preliminary Clinical Results from its AV Fistula Trials in Patients with Kidney Disease
Tue, 09/10/19 - 09:44 am
Vascular Therapies
clinical trials
Sirogen
chronic kidney disease
U.S. FDA gives fast track status to AstraZeneca's diabetes drug Farxiga
Yahoo/Reuters
Tue, 08/27/19 - 09:31 am
AstraZeneca
Farxiga
chronic kidney disease
FDA
fast track
AstraZeneca's Kidney Drug Roxadustat Gets Second Nod in China
Yahoo/Zacks.com
Fri, 08/23/19 - 10:04 am
AstraZeneca
FibroGen
China
roxadustat
chronic kidney disease
New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease
Xconomy
Fri, 08/23/19 - 09:48 am
Chinook Therapeutics
chronic kidney disease
Want Better Care for Kidney Disease group of Patients? Stop Excluding Them from Clinical Trials.
Xtalks
Fri, 07/12/19 - 09:47 am
clinical trials
chronic kidney disease
patients
Beyond glucose in type 2 diabetes: how Novo Nordisk is looking to address chronic kidney disease
Pharmaforum
Wed, 06/5/19 - 12:01 am
Novo Nordisk
type 2 diabetes
diabetes
chronic kidney disease
Vifor Pharma’s hypertension and CKD drug Veltassa meets primary endpoint in phase II study
Pharmaceutical Business Review
Mon, 05/13/19 - 09:25 am
Vifor
hypertension
chronic kidney disease
Veltassa
clinical trials
Little Proteon shares crash into penny stock territory as lead drug flops in PhIII
Endpoints
Thu, 03/28/19 - 10:16 am
Proteon Therapeutics
chronic kidney disease
vonapanitase
clinical trials
DiaMedica pulls off IPO to fund midphase stroke trial
Fierce Biotech
Fri, 12/7/18 - 10:44 am
IPOs
DiaMedica Therapeutics
chronic kidney disease
acute ischemic stroke
Reata stock surges on positive data in CKD patients
Biopharma Dive
Tue, 07/24/18 - 06:45 pm
Reata Pharmaceuticals
chronic kidney disease
Bardoxolone
J&J declares a historic success as Invokana comes through in PhIII chronic kidney disease trial
Endpoints
Mon, 07/16/18 - 10:24 pm
JNJ
Invokana
chronic kidney disease

Pages